Published on: 23.06.2020, 41 min.
In this webinar, Prof. Dr. Arnon Kater, Prof. Dr. Clemens Wendtner and Prof. Dr. Davide Rossi discuss three practice changing studies on CLL.
Study 1 summarised by Prof. Dr. Arnon Kater
Study 2 summarised by Prof. Dr. Clemens Wendtner
S155: FIXED-DURATION VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: FOLLOW-UP OF EFFICACY AND SAFETY RESULTS FROM THE MULTICENTER, OPEN-LABEL, RANDOMIZED PHASE 3 CLL14 TRIAL
Study 3 summarised by Prof. Dr. Davide Rossi
The webinar was independently produced and paid for by the MEDtalks Group of Companies.